Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.

Merck announced plans to acquire Verona Pharma for roughly $10 billion. 1 As part of the agreement between the two companies, Merck will add Verona’s COPD treatment Ohtuvayre to its cardio-pulmonary ...

"Morphoceuticals is building a platform that has the potential to transform human health,” said Pomerantz. "I am proud to ...

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...

Backed by an initial funding of $15 million from the National Science Foundation, the Regenerative Medicine Engine is the ...

The global 3D bioprinting market is set to witness a growth rate of 12-15% in the next 5 years. Rising demand for organ ...

EXCLUSIVE: New mum Zara was shattered when told she had bowel cancer, but a new drug trial at The Christie in Manchester has ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape, a process that can go haywire or fail to work. But what if the body could ...

Schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) are among the world’s most persistent neglected tropical diseases (NTDs) — a group of conditions that disproportionately affect the world ...